Quitting smoking during midlife or even later on can help slow down age-related cognitive decline, a new study suggests ...

When combined with PTSD and mild TBI, low-level blast exposure is associated with cognitive outcomes in military personnel.

Finally, don't put your mental health on the back burner. "Depression is a risk factor for dementia, and those feelings of ...

The test is intended for adults 55 and older in the United States who are showing signs or symptoms of cognitive decline.

BioArctic AB (publ) (NASDAQ Stockholm: BIOA B) announced today that Leqembi has now been made available at a private clinic in Finland and that the first patient has started treatment. BioArctic ...

Roche, which currently has investigational Alzheimer’s disease drug trontinemab in phase 3 trials, has secured FDA clearance of its blood-based biomarker test for the condition. | Roche, which ...

Viehbacher, “Biogen”) announced today that LEQEMBI ® IQLIK™, a subcutaneous autoinjector formulation of lecanemab (generic name), for the treatment of Alzheimer’s disease (AD) has been selected by ...

Indianapolis: Roche has announced that the United States Food and Drug Administration (FDA) has cleared its Elecsys pTau181 ...

Music has played a role in managing behavioral symptoms of Alzheimer’s disease, such as agitation, for a long time. That ...

Alzheimer’s disease can feel like a thief, sneaking in to steal memories, independence, and the moments that matter most. ...

We have seen how ketamine can work on depression and PTSD. New evidence suggests it can help with cognitive function as well, ...